Analyst Price Targets — SKIN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 20, 2026 12:24 pm | — | Roth Capital | $2.00 | $0.69 | TheFly | Beauty Health price target lowered to $2 from $2.50 at Roth Capital |
| May 1, 2026 10:48 am | — | Canaccord Genuity | $1.00 | $0.85 | TheFly | Beauty Health price target lowered to $1 from $1.50 at Canaccord |
| January 14, 2026 11:33 am | — | Jefferies | $1.60 | $1.53 | TheFly | Beauty Health assumed with a Hold at Jefferies |
| September 19, 2025 9:04 am | George Kelly | Roth Capital | $3.50 | $2.37 | TheFly | Beauty Health initiated with a Buy at Roth Capital |
| May 5, 2025 12:00 pm | Susan Anderson | Canaccord Genuity | $1.25 | $1.06 | TheFly | Beauty Health price target lowered to $1.25 from $1.50 at Canaccord |
| March 13, 2025 10:53 am | — | Canaccord Genuity | $1.50 | $1.34 | TheFly | Beauty Health price target lowered to $1.50 from $1.75 at Canaccord |
| August 9, 2024 8:49 am | Korinne Wolfmeyer | Piper Sandler | $1.00 | $1.14 | StreetInsider | The Beauty Health Company (SKIN) PT Lowered to $1 at Piper Sandler |
| May 10, 2024 8:22 am | Korinne Wolfmeyer | Piper Sandler | $2.50 | $3.26 | StreetInsider | The Beauty Health Company (SKIN) PT Lowered to $2.50 at Piper Sandler |
| March 13, 2024 6:42 am | Korinne Wolfmeyer | Piper Sandler | $3.00 | $4.25 | StreetInsider | The Beauty Health Company (SKIN) PT Raised to $3 at Piper Sandler |
| March 13, 2024 4:34 am | Jonathan Block | Stifel Nicolaus | $4.00 | $4.25 | StreetInsider | The Beauty Health Company (SKIN) PT Raised to $4 at Stifel |
Latest News for SKIN
SkinHealth Systems Inc. (SKIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars
An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair An advanced, non-invasive scalp treatment with no downtime, featuring newly engineered tips and clinically proven to visibly improve scalp health and the appearance of fuller, thicker-looking hair
Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beauty Health NASDAQ: SKIN, referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year over year to $8.5 million, exceeding the high end of its guidance range.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SKIN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.